fda and tirzepatide 🚨 Generic Versions of Mounjaro & Zepbound Move Closer as Reviews First Applications The US Food Drug Administration (FDA) is reviewing the first applications for generic versions of Eli Lilly's FDA OKs Zepbound for weight-loss

Antitumor activity of the IGF-1/IGF-2neutralizing antibody xentuzumab (BI 836845) in combination with enzalutamide in prostate cancer models

Anorexia is about 4 times more common in people with bipolar disorder than in the general population, an analysis of studies suggests

Many fat-loss compounds alter thyroid function, cortisol production, or sex hormone balance

Fecal but not plasma histidine levels positively correlated with the MGS index of favorable microbiota, the S-score previously reported to be associated with clinical benefit to ICI 66,67 (Fig

Reduced inflammatory inputs (processed carbs, excess sugar)

Watson WH, Greenwell JC, Zheng Y, Furmanek S, Torres-Gonzalez E, Ritzenthaler JD, et al